In recent years, a new marker, trichorhinophalangeal syndrome type 1, also known as transcriptional repressor GATA binding 1 (TRPS1), has been found to be a breast cancer marker with high specificity and sensitivity. This evidence concerns the gene TRPS1 and breast carcinoma.